Could psychedelics open new doors for science and business? : psychedelic medicines and therapies are becoming more mainstream and may offer innovative solutions in an era of declining mental health and well-being

Could psychedelics open new doors for science and business? psychedelic medicines and therapies are becoming more mainstream and may offer innovative solutions in an era of declining mental health and well-being

Psychedelic drugs have a history clouded by stigma, but a new wave of clinical research could change how they're perceived and used. Today, a psychedelic renaissance points to potential uses of such drugs in the fields of psychiatry, mental health, and well-being. Some companies have seized upo...

Descripción completa

Detalles Bibliográficos
Otros Autores: Meister, Alyson, author (author), Oppegaard, Kaja, author, Grotefeld, Eric, author, Bouquet, Cyril, author
Formato: Libro electrónico
Idioma:Inglés
Publicado: [Cambridge, Massachusetts] : MIT Sloan Management Review 2022.
Edición:[First edition]
Materias:
Hallucinogenic drugs > Therapeutic use.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009823028506719
Descripción
Sumario:Psychedelic drugs have a history clouded by stigma, but a new wave of clinical research could change how they're perceived and used. Today, a psychedelic renaissance points to potential uses of such drugs in the fields of psychiatry, mental health, and well-being. Some companies have seized upon psychedelics' potential to treat psychological conditions and spur creativity and are making business investments that they hope will pay off in breakthroughs that improve people's lives.
Notas:"Reprint 64230."
Descripción Física:1 online resource (5 pages)

Ejemplares similares